# Bioequivalence Study Comparing Single Dose of Ferrinemia® Injection With a Single Dose of Venofer® Injection in Healthy Male Volunteers

> **NCT03093883** · PHASE1 · COMPLETED · sponsor: **Azad Pharma AG** · enrollment: 48 (actual)

## Conditions studied

- Heathy Volunteers

## Interventions

- **DRUG:** Ferrinemia
- **DRUG:** Venofer

## Key facts

- **NCT ID:** NCT03093883
- **Lead sponsor:** Azad Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-13
- **Primary completion:** 2017-11-14
- **Final completion:** 2018-06-26
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03093883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03093883, "Bioequivalence Study Comparing Single Dose of Ferrinemia® Injection With a Single Dose of Venofer® Injection in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03093883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
